Aphios Granted U.S. Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases, which was co-invented by LSU Health Shreveport professor, Dr. J. Steven Alexander.
Welcome to the Department of Molecular and Cellular PhysiologyPhysiology is the study of how biological systems perform their functions to maintain the steady-state internal environment of living organisms. We can study these processes at the genetic, cellular, organ system or whole-animal level. Our departmental name reflects the increasing application of molecular biology techniques in the understanding of physiological function. Understanding the basic concepts of physiological control of organ systems in the human body is key to identifying regulatory processes during organ dysfunction and disease states which, in turn, may elucidate a novel approach in therapeutic intervention.
Graduate Program Applications are now being accepted for the 2020 / 21 Academic Year.
PO Box 33932
Shreveport, LA 71130-3932
Phone: (318) 675-6011
The Spring 2020 Seminar Series will begin on January 29. The scheduled speaker is Jeffery Chancellor, Ph.D. He is an Assistant Professor of Physics at LSU Baton Rouge.
JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD), TV1001SR, which was invented by LSU Health Shreveport professor and vice chancellor for research, Dr. Chris Kevil.
LSU Health Shreveport researchers recently presented preliminary findings at the American Heart Association’s Basic Cardiovascular Sciences 2019 Scientific Sessions that use of the illegal stimulant methamphetamine causes build-up of tough protein fibers in heart muscle, which may help explain the development of enlarged hearts and heart failure in users.
Zaki Al Yafeai, Dr. Celeste Wu, Dr. Shafiul Alam and Alexandre Do Couto E Silva were recognized as American Heart Association Fellowship recipients.
Christopher Pattillo, PhD, Associate Professor of Molecular and Cellular Physiology, has received a grant from the National Heart, Lung, and Blood Institute of the NIH for his five-year project, “Cellular Reductive State Regulates Arteriogenesis.”
A paper authored by many researchers at LSU Health Shreveport on the prevention and treatment of stroke was recently published in Circulation, a journal of the American Heart Association.
Gaganpreet Kaur and Mansoureh Barzega have been awarded Malcolm-Feist Pre-Doctoral Fellowships by the Center for Cardiovascular Diseases and Sciences.
Zaki Al-Yafeai, Physiology graduate student, was recently awarded an American Heart Association Predoctoral Fellowship Award.
Mansoureh Barzegar received the Inaugural William Halpern travel award from Microcirculatory Society which was given to the top scored applicant.
The LSU Health Shreveport Department of Molecular & Cellular Physiology and Aphios Corporation have obtained United States Patent No. 9,994,585 entitled “Transplantation Therapies,” for marine pharmaceutical ‘Bryostatin-1,’ which will be used as an additive to organ transport and storage solutions.